Solute carrier family (SLC) amino acid transporters are upregulated in cutaneous squamous cell carcinoma
Authors:
Open Access
- 12 January 2026
- journal article
- research article
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Abstract
Solute carrier family (SLC) amino acid transporters play key role in maintaining a continuous supply of nutrients to cancer cells. Non melanoma skin tumourKeywords
This publication has 51 references indexed in Scilit:
- Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acidBiochemical and Biophysical Research Communications, 2025
- High-Throughput Metabolomic Profiling of Skin Lesions: Comparative Study of Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, and Normal Skin Via e-Biopsy SamplingCellular and Molecular Bioengineering, 2025
- SLC7A5 is required for cancer cell growth under arginine-limited conditionsCell Reports, 2025
- Microenvironmental β-TrCP negates amino acid transport to trigger CD8+ T cell exhaustion in human non-small cell lung cancerCell Reports, 2025
- Comprehensive review of amino acid transporters as therapeutic targetsInternational Journal of Biological Macromolecules, 2024
- Metabolic regulation by p53 prevents R-loop-associated genomic instabilityCell Reports, 2022
- Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell CarcinomaCell, 2020
- First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumorsInvestigational New Drugs, 2020
- Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome AtlasCell Reports, 2019
- Cutaneous squamous cell carcinomaJournal of the American Academy of Dermatology, 2018